STE

BioSig Technologies, Inc. (STEX) Q3 2024 Earnings

STEX·Reported September 30, 2024·Before market open

Diluted EPS came in at $-0.12, missed the $-0.10 consensus by $0.02.

Diluted EPS

$-0.12missed by $0.02

Consensus: $-0.10

SEC Filings

Earnings release8-K not filed yet

Quarterly report10-Q · 0001493152-24-045687

Financial Snapshot

Trailing eight quarters through Q3 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q3 2024 Earnings FAQ

Common questions about BioSig Technologies, Inc.'s Q3 2024 earnings report.

BioSig Technologies, Inc. (STEX) reported Q3 2024 earnings on September 30, 2024 before market open.

BioSig Technologies, Inc. reported diluted EPS of $-0.12 for Q3 2024.

EPS missed the consensus estimate of $-0.10 by $0.02.

You can read the 10-Q periodic report (0001493152-24-045687) directly on SEC EDGAR. The filing index links above go to sec.gov.